In all models, BRD4 inhibition reduced tumor volumes, and in the 4T1 model treated with PLX51107, this effect reached statistical significance, suggesting that the reductions in MDSC numbers could be due to reduced tumor burden (Supplemental Figure 2A). Here, BRD4 is linked to neoplasm.